Reply: Should We Be for ASCT?: If Yes, Then When?

Free article

Comment

Ronald M Witteles et al. JACC Heart Fail. 2020 Aug.

Free article

. 2020 Aug;8(8):696-697.

doi: 10.1016/j.jchf.2020.05.008.

No abstract available

Comment on

Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation.
Barrett CD, Alexander KM, Zhao H, Haddad F, Cheng P, Liao R, Wheeler MT, Liedtke M, Schrier S, Arai S, Weisshaar D, Witteles RM. Barrett CD, et al. JACC Heart Fail. 2020 Jun;8(6):461-468. doi: 10.1016/j.jchf.2019.12.013. Epub 2020 May 6. JACC Heart Fail. 2020. PMID: 32387068
Should We Be for ASCT?: If Yes, Then When?
Trachtenberg BH, Kamble R, Bhimaraj A, Estep JD. Trachtenberg BH, et al. JACC Heart Fail. 2020 Aug;8(8):695-696. doi: 10.1016/j.jchf.2020.05.009. JACC Heart Fail. 2020. PMID: 32731949 No abstract available.